Schmitz, Alexander ; Brondum, Rasmus Froberg ; Johnsen, Hans Erik...
BMC Cancer, 1471-2407, 2022, 22:1,.  , 2022

Schmitz, Alexander ; Brøndum, Rasmus Froberg ; Johnsen, Hans Erik...
BMC Cancer. 2022, 22:147 (1), 1-11..  , 2022

Schmitz, Alexander ; Brøndum, Rasmus Froberg ; Johnsen, Hans Erik...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818194/.  , 2022

Schmitz, Alexander ; Brøndum, Rasmus F ; Johnsen, Hans E...
http://urn.nb.no/URN:NBN:no-93244.  , 2022

Schmitz, Alexander ; Brøndum, Rasmus Froberg ; Johnsen, Hans Erik...
Schmitz , A , Brøndum , R F , Johnsen , H E , Mellqvist , U H , Waage , A , Gimsing , P , Op Bruinink , D H , van der Velden , V , van der Holt , B , Hansson , M , Andersen , N F , Frølund , U C , Helleberg , C , Schjesvold , F H , Ahlberg , L , Gulbrandsen , N , Andreasson , B , Lauri , B , Haukas , E , Bødker , J S , Roug , A S , Bøgsted , M , Severinsen , M T , Gregersen , H , Abildgaard , N , Sonneveld , P & Dybkær , K 2022 , ' Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial ' , BMC Cancer , vol. 22 , no. 1 , 147 , pp. 147 . https://doi.org/10.1186/s12885-022-09184-1.  , 2022

Schmitz, Alexander ; Brøndum, Rasmus Froberg ; Johnsen, Hans Erik...
Schmitz , A , Brøndum , R F , Johnsen , H E , Mellqvist , U H , Waage , A , Gimsing , P , Op Bruinink , D H , van der Velden , V , van der Holt , B , Hansson , M , Andersen , N F , Frølund , U C , Helleberg , C , Schjesvold , F H , Ahlberg , L , Gulbrandsen , N , Andreasson , B , Lauri , B , Haukas , E , Bødker , J S , Roug , A S , Bøgsted , M , Severinsen , M T , Gregersen , H , Abildgaard , N , Sonneveld , P & Dybkær , K 2022 , ' Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial ' , BMC Cancer , vol. 22 , 147 . https://doi.org/10.1186/s12885-022-09184-1.  , 2022

Schmitz, Alexander ; Brøndum, Rasmus Froberg ; Johnsen, Hans Erik...
Schmitz , A , Brøndum , R F , Johnsen , H E , Mellqvist , U H , Waage , A , Gimsing , P , op Bruinink , D H , van der Velden , V , van der Holt , B , Hansson , M , Andersen , N F , Frølund , U C , Helleberg , C , Schjesvold , F H , Ahlberg , L , Gulbrandsen , N , Andreasson , B , Lauri , B , Haukas , E , Bødker , J S , Roug , A S , Bøgsted , M , Severinsen , M T , Gregersen , H , Abildgaard , N , Sonneveld , P & Dybkær , K 2022 , ' Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial ' , BMC Cancer , vol. 22 , no. 1 , 147 . https://doi.org/10.1186/s12885-022-09184-1.  , 2022

Schmitz, Alexander ; Brøndum, Rasmus Froberg ; Johnsen, Hans Erik...
https://vbn.aau.dk/da/publications/efb33919-5315-458f-a0de-0566f04c6bdb.  , 2022

Redder, Louise ; Klausen, Tobias W ; Vangsted, Annette Juul...
Redder , L , Klausen , T W , Vangsted , A J , Gregersen , H , Andersen , N F , Pedersen , R S , Szabo , A G , Frederiksen , M , Frølund , U C , Helleberg , C , Nielsen , L K , Pedersen , P T , Salomo , M , Gimsing , P , Frederiksen , H & Abildgaard , N 2021 , ' Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation : a population-based study from the Danish national multiple myeloma registry ' , British Journal of Haematology , vol. 193 , no. 1 , pp. 119-124 . https://doi.org/10.1111/bjh.16806.  , 2021

Redder, Louise ; Klausen, Tobias W ; Vangsted, Annette Juul...
https://vbn.aau.dk/da/publications/aa9f3e41-576c-4296-92c3-140001af08a4.  , 2021

Nielsen, Lene Kongsgaard ; Stege, Claudia ; Lissenberg-Witte, Birgit...
Nielsen , L K , Stege , C , Lissenberg-Witte , B , van der Holt , B , Mellqvist , U-H , Salomo , M , Bos , G , Levin , M-D , Visser-Wisselaar , H , Hansson , M , van der Velden , A , Deenik , W , Coenen , J , Hinge , M , Klein , S , Tanis , B , Szatkowski , D , Brouwer , R , Westerman , M , Leys , R , Sinnige , H , Haukås , E , van der Hem , K , Durian , M , Gimsing , P , van de Donk , N , Sonneveld , P , Waage , A , Abildgaard , N & Zweegman , S 2020 , ' Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression : a prospective, open-label, multicenter, randomized, phase 3 study ' , Haematologica-the Hematology Journal , vol. 105 , no. 6 , pp. 1650-1659 . https://doi.org/10.3324/haematol.2019.222299.  , 2020

Nielsen, Lene Kongsgaard ; Stege, Claudia ; Lissenberg-Witte, Birgit...
Nielsen , L K , Stege , C , Lissenberg-Witte , B , van der Holt , B , Mellqvist , U-H , Salomo , M , Bos , G , Levin , M-D , Visser-Wisselaar , H , Hansson , M , van der Velden , A , Deenik , W , Coenen , J , Hinge , M , Klein , S , Tanis , B , Szatkowski , D , Brouwer , R , Westerman , M , Leys , R , Sinnige , H , Haukås , E , van der Hem , K , Durian , M , Gimsing , P , van de Donk , N , Sonneveld , P , Waage , A , Abildgaard , N & Zweegman , S 2020 , ' Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression : a prospective, open-label, multicenter, randomized, phase 3 study ' , Haematologica , vol. 105 , no. 6 , pp. 1650-1659 . https://doi.org/10.3324/haematol.2019.222299.  , 2020

Nielsen, Lene Kongsgaard ; Stege, Claudia ; Lissenberg-Witte, Birgit...
Nielsen , L K , Stege , C , Lissenberg-Witte , B , van der Holt , B , Mellqvist , U-H , Salomo , M , Bos , G , Levin , M-D , Visser-Wisselaar , H , Hansson , M , van der Velden , A , Deenik , W , Coenen , J , Hinge , M , Klein , S , Tanis , B , Szatkowski , D , Brouwer , R , Westerman , M , Leys , R , Sinnige , H , Haukås , E , van der Hem , K , Durian , M , Gimsing , P , van de Donk , N , Sonneveld , P , Waage , A , Abildgaard , N & Zweegman , S 2020 , ' Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression : a prospective, open-label, multicenter, randomized, phase 3 study ' , Haematologica , vol. 105 , no. 6 , pp. 1650-1659 . https://doi.org/10.3324/haematol.2019.222299.  , 2020

Nielsen, Lene Kongsgaard ; Stege, Claudia ; Lissenberg-Witte, Birgit I...
urn:issn:0390-6078.  , 2019

Lund, Johan ; Gruber, Astrid ; Lauri, Birgitta...
Cancer Medicine. 2018, 7 (6), 2256-2268..  , 2018